BCG in T1G3 bladder cancer: Our experience;RUOLO DEL BCG NEL CARCINOMA VESCICALE TRANSIZIONALE (TCC) T1G3: NOSTRA ESPERIENZA

Archivio Italiano di Urologia e Andrologia

Volumn 68, Issue 1, 1996, Pages 55-59

  Comeri, G C ^a   Belvisi, P ^a   Conti, G ^a   Cretarola, E ^a   Duvia, R ^a   Furgoni, R ^a   Gianneo, E ^a   Radice, G P ^a  

^a SANT ANNA HOSPITAL   (Italy)

Author keywords

BCG; bladder; superficial transitional cell carcinoma

Indexed keywords

BCG VACCINE;

BLADDER CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FOLLOW UP; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; REGIONAL PERFUSION; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0029935629     PISSN: 11208538     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)